JPMorgan Chase & Co. Grows Position in Healthpeak Properties, Inc. $DOC

JPMorgan Chase & Co. grew its position in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 41.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 28,236,534 shares of the real estate investment trust’s stock after acquiring an additional 8,212,504 shares during the quarter. JPMorgan Chase & Co.’s holdings in Healthpeak Properties were worth $540,730,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the company. Mather Group LLC. bought a new position in shares of Healthpeak Properties during the third quarter valued at about $25,000. City Holding Co. purchased a new stake in Healthpeak Properties in the 3rd quarter valued at about $26,000. Rexford Capital Inc. purchased a new stake in Healthpeak Properties in the 2nd quarter valued at about $28,000. Sound Income Strategies LLC bought a new position in shares of Healthpeak Properties during the 3rd quarter worth approximately $28,000. Finally, Elevation Point Wealth Partners LLC purchased a new position in shares of Healthpeak Properties in the 2nd quarter worth approximately $32,000. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Down 0.6%

DOC stock opened at $17.12 on Thursday. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.82 and a current ratio of 2.82. The company has a market capitalization of $11.90 billion, a price-to-earnings ratio of 171.17, a PEG ratio of 9.24 and a beta of 1.12. Healthpeak Properties, Inc. has a fifty-two week low of $15.71 and a fifty-two week high of $21.28. The stock has a fifty day moving average of $16.81 and a 200-day moving average of $17.55.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.45 by $0.02. The business had revenue of $719.40 million for the quarter, compared to analysts’ expectations of $685.14 million. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The firm’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period in the previous year, the business posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, equities research analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be paid a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 7.1%. The ex-dividend date is Tuesday, March 17th. Healthpeak Properties’s dividend payout ratio is presently 1,220.00%.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on DOC. Jefferies Financial Group lowered Healthpeak Properties from a “buy” rating to a “hold” rating and dropped their price target for the stock from $21.00 to $17.00 in a report on Monday, December 15th. Evercore decreased their target price on Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating for the company in a research report on Wednesday, February 4th. Wells Fargo & Company reissued a “positive” rating on shares of Healthpeak Properties in a report on Tuesday, February 3rd. Cantor Fitzgerald set a $17.00 price objective on shares of Healthpeak Properties in a report on Monday, January 5th. Finally, Argus lowered shares of Healthpeak Properties from a “buy” rating to a “hold” rating in a research report on Thursday, February 5th. Six research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, Healthpeak Properties has a consensus rating of “Hold” and a consensus price target of $19.42.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.